1966
DOI: 10.1001/archpedi.1966.02090110068005
|View full text |Cite
|
Sign up to set email alerts
|

Tape Recorder for Evaluation of Coughs in Children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
5

Year Published

1995
1995
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 5 publications
0
15
0
5
Order By: Relevance
“…[9][10][11][12][13][14] Study characteristics Table 3 summarises the characteristics of included RCTs which we grouped into five drug classes (see table 1). The number of trials in each group ranged from one to a maximum of two.…”
Section: Trial Flowmentioning
confidence: 99%
“…[9][10][11][12][13][14] Study characteristics Table 3 summarises the characteristics of included RCTs which we grouped into five drug classes (see table 1). The number of trials in each group ranged from one to a maximum of two.…”
Section: Trial Flowmentioning
confidence: 99%
“…The methods using the measurements of airflow during coughing have also been used in cough counting (14,15). Then the number of cough events was counted off-line by researchers using unfiltered recording of cough sounds obtained with a free-field microphone and a cassette recorder (7,16). In these studies, some researchers have recorded cough sounds with a contact microphone (17)(18)(19), and have measured both airflow and sound pressure in the front of the mouth during coughing (14,(20)(21)(22)(23)(24).…”
Section: Finally We Designed a Cough Counting Program As Follows (Figmentioning
confidence: 99%
“…In an early study, the efficacy of two cough-suppressant preparations was assessed in 43 children (aged 2 months-12 years; average 3.6 years) presenting principally with a cough, in general practice 5. Participants were assigned to: syrup A (Triaminicol syrup, containing dextromethorphan hydrobromide 15mg/5mL, phenylpropanolamine hydrochloride 12.5mg/5mL, pheniramine maleate 6.25mg/5mL, pyrilamine maleate 6.25mg/5mL and ammonium chloride 90mg/mL); syrup B (Dorcal syrup, containing dextromethorphan hydrobromide 7.5mg/5mL, phenylpropanolamine hydrochloride 8.75mg/5mL, glyceryl guaiacolate 37.5mg/5mL and alcohol 5%); or syrup C (placebo containing no 'active' ingredients but resembling syrup B in colour and taste).…”
Section: Clinical Studiesmentioning
confidence: 99%